# OnCo record nct03519230 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03519230/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03519230", "NCT03519230" ;
  schema:name "Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer"@en ;
  schema:description "A phase 3 trial of Pamiparib capsule in ovarian cancer, run by BeiGene, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03519230/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03519230> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2018-05-14" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/platinum-sensitive-ovarian-cancer/> ;
  onco:drugs <https://onco.cc/drugs/pamiparib/> ;
  onco:companies <https://onco.cc/companies/beone/> .
